Figure 3.

Receiver operating characteristic (ROC) curves for (a) Eno5-21, (b) Vim60-75, and (c) FibĪ²60-74. The analyses were based on comparisons between 927 RA patients (43.3% anti-CCP2 positive) and 461 healthy controls. AUC, Area under the curve.

Hansson et al. Arthritis Research & Therapy 2012 14:R201   doi:10.1186/ar4039
Download authors' original image